A phase II study of azacitidine in combination with granulocyte-macrophage colony-stimulating factor as maintenance treatment, after allogeneic blood or marrow transplantation in patients with poor-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
Leuk Lymphoma
; 62(13): 3181-3191, 2021 12.
Article
em En
| MEDLINE
| ID: mdl-34284701
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Síndromes Mielodisplásicas
/
Leucemia Mieloide Aguda
/
Transplante de Células-Tronco Hematopoéticas
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article